About Ercros
Ticker
info
ECR
Trading on
info
MC
ISIN
info
ES0125140A14
Industry
info
Chemicals
Sector
info
Basic Materials
CEO
info
Antonio Zabalza Marti
Headquarters
info
Avinguda Diagonal, 593-595, Barcelona, undefined, Spain, 08014
Employees
info
1,357
Website
info
ercros.es
Ercros, S.A. manufactures and sells basic chemicals, intermediate chemicals, and pharmaceuticals in Spain. It operates through three segments: Chlorine Derivatives, Intermediate Chemicals, and Pharmacy. The Chlorine Derivatives segment produces ammonia, bioplastics, caustic potash and soda, chlorine, chloroisocyanurates, dicalcium phosphate, dichloroethane, hydrochloric acid, hydrogen peroxide, potassium carbonate, PVC compounds, sodium chlorate and chlorite, sodium hypochlorite, and vinyl chloride monomers and polychloride. This segment's products are used as intermediates in other industrial processes to purify and treat drinking and waste water; treat and maintain swimming pool water; bleach fabrics and paper; produce solvents, detergents, and strippers; manufacture printing inks and coloring; to produce compound feed and in cooling equipment. The Intermediate Chemicals segment provides formaldehyde, glues and resins, molding compunds, paraformaldehyde, pentaerythritol and dipentaerythritol, and sodium formate for manufacturing of particle, and decorative laminates and plywoods, as well as resins, paints, and varnishes in the furniture and decoration industry; sockets and switches in the electrical components sector; and tableware, and health and packaging items in the textile tanning industry. The Pharmacy division engages in the production of raw materials and pharmaceutical intermediate products from antibiotic, cholesterol-lowering, anti-ulcer, and anti-fungal agents. This segment's products include amlodipine besylate, azithromycin, clarithromycin, erythromycins, famotidine, fosfomycin calcium and sodium, fosfomycin trometamol, and fusidic acid. The company is also involved in exporting activities. Ercros, S.A. was founded in 1817 and is headquartered in Barcelona, Spain.
Metrics
BasicAdvanced
Market cap
info
€248M
P/E ratio
info
-
EPS
info
-€0.46
Dividend Yield
info
0.00%
Beta
info
0.67
Forward P/E ratio
info
14.99
EBIDTA
info
€-9.9M
Ex dividend date
info
2024-07-08
Price & volume
Market cap
info
€248M
Average daily volume
info
0.1M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
€0.00
Dividend yield
info
0.00%
Forward dividend per share
info
€0.00
Forward dividend yield
info
0.00%
Payout ratio
info
65.30%
Valuation
P/E ratio
info
0
Forward P/E
info
14.99
PEG ratio
info
0.29
Trailing P/E
info
0
Price to sales
info
0.38
Price to book
info
0.79
Earnings
EPS
info
-€0.46
EPS estimate (current quarter)
info
€0.00
EPS estimate (next quarter)
info
€0.00
EBITDA
info
€-9.9M
Revenues (TTM)
info
€655M
Revenues per share (TTM)
info
€7.22
Technicals
Beta
info
0.67
52-week High
info
€3.72
52-week Low
info
€2.58
50-day moving average
info
€2.87
200-day moving average
info
€3.07
Short ratio
info
0
Short %
info
0.00%
Management effectiveness
ROE (TTM)
info
-12.69%
ROA (TTM)
info
-2.95%
Profit margin
info
-6.46%
Gross profit margin
info
€183M
Operating margin
info
-1.21%
Growth
Quarterly earnings growth (YoY)
info
-19.60%
Quarterly revenue growth (YoY)
info
-5.30%
Share stats
Outstanding Shares
info
91.4M
Float
info
75.8M
Insiders %
info
17.16%
Institutions %
info
13.27%
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-€0.08
-
-
Q1 • 09Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
€179M
€-12.2M
-6.81%
Q1 • 25
€168M
€-17.1M
-10.21%
Q2 • 25
-6.18%
40.66%
49.92%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
€643M
€314M
48.85%
Q1 • 25
€740M
€429M
57.91%
Q2 • 25
15.08%
36.43%
18.55%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
-
-
-
-
Q1 • 25
€10.3M
-
€53.3M
€-2M
Q2 • 25
-
-
NaN%
NaN%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Ercros share?
Collapse

Ercros shares are currently traded for undefined per share.

How many shares does Ercros have?
Collapse

Ercros currently has 91.4M shares.

Does Ercros pay dividends?
Collapse

No, Ercros doesn't pay dividends.

What is Ercros 52 week high?
Collapse

Ercros 52 week high is €3.72.

What is Ercros 52 week low?
Collapse

Ercros 52 week low is €2.58.

What is the 200-day moving average of Ercros?
Collapse

Ercros 200-day moving average is €3.07.

Who is Ercros CEO?
Collapse

The CEO of Ercros is Antonio Zabalza Marti.

How many employees Ercros has?
Collapse

Ercros has 1,357 employees.

What is the market cap of Ercros?
Collapse

The market cap of Ercros is €248M.

What is the P/E of Ercros?
Collapse

The current P/E of Ercros is null.

What is the EPS of Ercros?
Collapse

The EPS of Ercros is -€0.46.

What is the PEG Ratio of Ercros?
Collapse

The PEG Ratio of Ercros is 0.29.